0001764013-26-000055.txt : 20260424 0001764013-26-000055.hdr.sgml : 20260424 20260424160556 ACCESSION NUMBER: 0001764013-26-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260423 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stout Jay S CENTRAL INDEX KEY: 0001702969 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38906 FILM NUMBER: 26893583 MAIL ADDRESS: STREET 1: C/O VERSARTIS, INC. STREET 2: 4200 BOHANNON DR., SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunovant, Inc. CENTRAL INDEX KEY: 0001764013 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 832771572 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1000 PARK FORTY PLAZA CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 917-410-3120 MAIL ADDRESS: STREET 1: 1000 PARK FORTY PLAZA CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp DATE OF NAME CHANGE: 20190108 4 1 wk-form4_1777061153.xml FORM 4 X0609 4 2026-04-23 0 0001764013 Immunovant, Inc. IMVT 0001702969 Stout Jay S false C/O IMMUNOVANT, INC. 1000 PARK FORTY PLAZA, SUITE 210 DURHAM NC 27713 0 1 0 0 Chief Technology Officer 0 Common Stock 2026-04-23 4 S 0 2754 29.62 D 251685 D On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on April 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. /s/ Tiago Girao, attorney-in-fact for Jay Stout 2026-04-24